For the record, I am a believer and have never thought GC to be "dishonest". Circumstances and timeframes always change in a world that most decisions are predicated upon FDA schedules and permission.
This will be an informative week for AMBS, especially with shareholder reactions (either way) ***
Best, BsR
(0)
(0)
Amarantus Bioscience Holdings (AMBS) Stock Research Links